Top

Published in:

14-11-2023 | Lung Cancer

Enhancing Symptom Screening and Patient Education Among Patients with Metastatic Lung Cancer: a Qualitative Analysis

Authors: Amir H. Safavi, Emily Bryson, Victoria Delibasic, Michael C. Tjong, Julie Hallet, Alyson Mahar, Laura E. Davis, Frances C. Wright, Ambica Parmar, Natalie G. Coburn, Alexander V. Louie

Published in: Journal of Cancer Education | Issue 1/2024

Abstract

We explored perspectives of patients with metastatic non-small cell lung cancer (mNSCLC) on symptom screening and population-level patient-reported outcome (PRO) data regarding common symptom trajectories in the year after diagnosis. A qualitative study of patients with mNSCLC was conducted at a Canadian tertiary cancer centre. English-speaking patients diagnosed ≥ 6 months prior to study invitation were recruited, and semi-structured one-on-one interviews were conducted. Patient and treatment characteristics were obtained via chart review. Anonymized interview transcripts underwent deductive-inductive coding and thematic content analysis. Among ten participants (5 (50%) females; median (range) age, 68 (56–77) years; median (range) time since diagnosis, 28.5 (6–72) months; 6 (60%) with smoking histories), six themes were identified in total. Two themes were identified regarding symptom screening: (1) screening is useful for symptom self-monitoring and disclosure to the healthcare team, (2) screening of additional quality-of-life (QOL) domains (smoking-related stigma, sexual dysfunction, and financial toxicity) is desired. Four themes were identified regarding population-level symptom trajectory PRO data: (1) data provide reassurance and motivation to engage in symptom self-management, (2) data should be disclosed after an oncologic treatment plan is developed, (3) data should be communicated via in-person discussion with accompanying patient-education resources, and (4) communication of data should include reassurance about symptom stabilization, acknowledgement of variability in patient experience, and strategies for symptom self-management. The themes and recommendations derived from the patient experience with mNSCLC provide guidance for enhanced symptom screening and utilization of population-level symptom trajectory data for patient education.

Available only for authorised users

Miller KD, Nogueira L, Devasia T et al (2022) Cancer treatment and survivorship statistics, 2022. CA: Cancer J Clin 0:1–28. https://doi.org/10.3322/caac.21731CrossRef

Reilly CM, Bruner DW, Mitchell SA et al (2013) A literature synthesis of symptom prevalence and severity in persons receiving active cancer treatment. Support Care Cancer 21(6):1525–1550. https://doi.org/10.1007/s00520-012-1688-0CrossRefPubMedPubMedCentral

Tjong MC, Doherty M, Tan H et al (2021) Province-wide analysis of patient-reported outcomes for stage IV non-small cell lung cancer. Oncologist 26(10):e1800-1811. https://doi.org/10.1002/onco.13890CrossRefPubMedPubMedCentral

Howell D, Mayer DK, Fielding R, Global Partners for Self-Management in Cancer et al (2021) Management of cancer and health after the clinic visit: a call to action for self-management in cancer care. J Natl Cancer Inst 113(5):523–531. https://doi.org/10.1093/jnci/djaa083CrossRefPubMed

Maguire R, Papadopoulou C, Kotronoulas G et al (2013) A systematic review of supportive care needs of people living with lung cancer. Eur J Oncol Nurs 17(4):449–464. https://doi.org/10.1016/j.ejon.2012.10.013CrossRefPubMed

Pereira J, Green E, Molloy S et al (2014) Population-based standardized symptom screening: Cancer Care Ontario’s Edmonton Symptom Assessment System and performance status initiatives. J Oncol Pract 10(3):212–214. https://doi.org/10.1200/JOP.2014.001390CrossRefPubMed

Carter SM, Little M (2007) Justifying knowledge, justifying method, taking action: epistemologies, methodologies, and methods in qualitative research. Qual Health Res 17(10):1316–1328. https://doi.org/10.1177/1049732307306927CrossRefPubMed

O’Brien BC, Harris IB, Beckman TJ et al (2014) Standards for reporting qualitative research: a synthesis of recommendations. Acad Med 89(9):1245–1251. https://doi.org/10.1097/ACM.0000000000000388CrossRefPubMed

International Association for the Study of Lung Cancer. IASLC Language Guide. IASLC 2022. Available at https://www.iaslc.org/IASLCLanguageGuide. Accessed June 29, 2022

10.

Hennink M, Kaiser BN (2022) Sample sizes for saturation in qualitative research: a systematic review of empirical tests. Soc Sci Med 292:114523.https://doi.org/10.1016/j.socscimed.2021.114523

11.

Braun V, Clarke V (2021) To saturate or not to saturate? Questioning data saturation as a useful concept for thematic analysis and sample-size rationales. Qual Res Sport Exerc Health 13(2):201–216. https://doi.org/10.1080/2159676X.2019.1704846CrossRef

12.

Braun V, Clarke V (2016) (Mis)conceptualizing themes, thematic analysis, and other problems with Fungard and Potts’ (2015) sample-size tool for thematic analysis. Int J Soc Res Methodol 19(6):739–743. https://doi.org/10.1080/13645579.2016.1195588CrossRef

13.

Saunders B, Sim J, Kingstone T et al (2018) Saturation in qualitative research: exploring its conceptualization and operationalization. Qual Quant 52(4):1893–1907. https://doi.org/10.1007/s11135-017-0574-8CrossRefPubMed

14.

Hirpara DH, Gupta V, Davis LE et al (2020) Severe symptoms persist for up to one year after diagnosis of stage I-III lung cancer: an analysis of province-wide patient reported outcomes. Lung Cancer 142:808–889. https://doi.org/10.1016/j.lungcan.2020.02.014CrossRef

15.

Fereday J, Muir-Cochrane E (2006) Demonstrating rigor using thematic analysis: a hybrid approach of inductive and deductive coding and theme development. Int J Qual Methods 5(1):80–92. https://doi.org/10.1777/160940690600500107CrossRef

16.

Noel CW, Du Y, Baran E et al (2022) Enhancing outpatient symptom management in patients with head and neck cancer: a qualitative analysis. JAMA Otolaryngol Head Neck Surg 148(4):333–341. https://doi.org/10.1001/jamaoto.2021.4555CrossRefPubMedPubMedCentral

17.

Watanabe S, Nekolaichuk C, Beaumont C et al (2009) The Edmonton Symptom Assessment System–what do patients think? Support Care Cancer 17(6):675–683. https://doi.org/10.1007/s00520-008-0522-1CrossRefPubMed

18.

Smith GL, Banegas MP, Acquati C et al (2022) Navigating financial toxicity in patients with cancer: a multidisciplinary management approach. CA Cancer J Clin. https://doi.org/10.3322/caac.21730CrossRefPubMed

19.

Cataldo JK, Slaughter R, Jahan TM et al (2011) Measuring stigma in people with lung cancer: psychometric testing of the Cataldo Lung Cancer Stigma Scale. Oncol Nurs Forum 38(1):E46–E54. https://doi.org/10.1188/11.ONF.E46-E54CrossRefPubMedPubMedCentral

20.

Budhwani S, Wodchis WP, Zimmermann C et al (2019) Self-management, self-management support needs and interventions in advanced cancer: a scoping review. BMJ Support Palliat Care 9(1):12–25. https://doi.org/10.1136/bmjspcare-2018-001529CrossRefPubMed

21.

Kleckner IR, Kamen C, Gewandter JS et al (2018) Effects of exercise during chemotherapy on chemotherapy-induced peripheral neuropathy: a multicenter, randomized control trial. Support Care Cancer 26(4):1019–1028. https://doi.org/10.1007/s00520-017-4013-0CrossRefPubMed

22.

Pilotto S, Avancini A, Menis J et al (2022) Exercise in lung cancer, the healthcare providers opinion (E.C.H.O.): results of the EORTC lung cancer group (LCG) survey. Lung Cancer 169:94–101. https://doi.org/10.1016/j.lungcan.2022.05.009CrossRefPubMed

23.

Petrillo LA, Shimer SE, Zhou AZ et al (2022) Prognostic communication about lung cancer in the precision oncology era: a multiple-perspective qualitative study. Cancer. https://doi.org/10.1002/cncr.34369CrossRefPubMed

24.

Bernacki R, Paladino J, Neville BA et al (2019) Effect of the Serious Illness Care Program in outpatient oncology: a cluster randomized clinical trial. JAMA Intern Med 179(6):751–759. https://doi.org/10.1001/jamainternmed.2019.0077CrossRefPubMedPubMedCentral

25.

Pereira JL, Chasen MR, Molloy S et al (2016) Cancer care professionals’ attitudes toward systematic standardized symptom assessment and the Edmonton Symptom Assessment System after large-scale population-based implementation in Ontario, Canada. J Pain Symptom Manage 51(4):662-672.e8. https://doi.org/10.1016/j.jpainsymman.2015.11.023CrossRefPubMed

26.

Barbera L, Seow H, Husain A et al (2012) Opioid prescription after pain assessment: a population-based cohort of elderly patients with cancer. J Clin Oncol 30(10):1095–1099. https://doi.org/10.1200/JCO.2011.37.3068CrossRefPubMed

27.

Hallet J, Davis LE, Isenberg-Grzeda E et al (2020) Gaps in the management of depression symptoms following cancer diagnosis: a population-based analysis of prospective patient-reported outcomes. Oncologist 25(7):e1098–e1108. https://doi.org/10.1634/theoncologist.2019-0709CrossRefPubMedPubMedCentral

28.

Denis F, Basch EM, Lethrosne C et al (2018) Randomized trial comparing a web-mediated follow-up via patient-reported outcomes (PRO) vs routine surveillance in lung cancer patients: final results. J Clin Oncol 36(15_suppl):6500. https://doi.org/10.1200/JCO.2018.36.15_suppl.6500CrossRef

29.

Basch E, Deal AM, Kris MG et al (2016) Symptom monitoring with patient-reported outcomes during routine cancer treatment: a randomized control trial. J Clin Oncol 34(6):557–565. https://doi.org/10.1200/JCO.2015.63.0830CrossRefPubMed

30.

Absolom K, Warrington L, Hudson E et al (2021) Phase III randomized controlled trial of eRAPID: eHealth intervention during chemotherapy. J Clin Oncol 39(7):734–747. https://doi.org/10.1200/JCO.20.02015CrossRef

31.

Smith HJ, Chen J, Liu X (2008) Language and rigour in qualitative research: problems and principles in analyzing data collected in Mandarin. BMC Med Res Methodol 8(44). https://doi.org/10.1186/1471-2288-8-44

Title: Enhancing Symptom Screening and Patient Education Among Patients with Metastatic Lung Cancer: a Qualitative Analysis
Authors: Amir H. Safavi
Emily Bryson
Victoria Delibasic
Michael C. Tjong
Julie Hallet
Alyson Mahar
Laura E. Davis
Frances C. Wright
Ambica Parmar
Natalie G. Coburn
Alexander V. Louie
Publication date: 14-11-2023
Publisher: Springer US
Keywords: Lung Cancer
Lung Cancer
Lung Cancer
Published in: Journal of Cancer Education / Issue 1/2024
Print ISSN: 0885-8195
Electronic ISSN: 1543-0154
DOI: https://doi.org/10.1007/s13187-023-02379-5

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 1/2024

A Novel Digital Educational Strategy Improves Treatment Adherence and Quality of Life in Patients with Multiple Myeloma

Feasibility and Impact of an Online Simulation Focusing on Nursing Communication About Sexual Health in Gynecologic Oncology

Assessing Disparities in Cervical Cancer Screening with Pap Test by Disability Types

Geriatric Communication Skills Training Program for Oncology Healthcare Providers: a Secondary Analysis of Patient and Caregiver Outcomes

Increasing Lung Cancer Screening for High-Risk Smokers in a Frontier Population

Effect of an Oncology Focused High School Outreach Event in Increasing Interest in Cancer Care and Healthcare Careers

Keynote webinar | Spotlight on antibody–drug conjugates in cancer